AP2 alpha/beta (AA 201-300) Antikörper
Kurzübersicht für AP2 alpha/beta (AA 201-300) Antikörper (ABIN1714083)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Verwendungszweck
- AP2 alpha + beta Polyclonal Antibody
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Dog,Sheep,Pig,Horse,Chicken,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AP2 alpha + beta
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- AP2 alpha/beta
-
Andere Bezeichnung
- AP2 alpha + beta
-
Hintergrund
-
Synonyms: Activating enhancer binding protein 2 alpha, Activating enhancer binding protein 2 beta, AP2TF, TFAP2, TFAP2A, TFAP2B, Transcription factor AP2 alpha, Transcription factor AP2 beta, AP2A_HUMAN, AP2B_HUMAN.
Background: The AP2 proteins are normally expressed in ectodermally derived vertebrate tissues where they are necessary for normal growth and development. The factors have also been implicated in the control of cell proliferation, viral transformation, and oncogenesis. AP2 seems to play in important role in human breast cancer. AP2 alpha is the only AP2 protein required for early morphogenesis of the lens vesicle. AP2 beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia.
-
Gen-ID
- 7021
Target
-